BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 11694206)

  • 41. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.
    Benowitz NL; Hall SM; Stewart S; Wilson M; Dempsey D; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2479-85. PubMed ID: 18006940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
    Cinciripini PM; Tsoh JY; Wetter DW; Lam C; de Moor C; Cinciripini L; Baile W; Anderson C; Minna JD
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):282-92. PubMed ID: 16366758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mecamylamine moderates cue-induced emotional responses in smokers.
    McClernon FJ; Rose JE
    Addict Behav; 2005 May; 30(4):741-53. PubMed ID: 15833578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes.
    Buchhalter AR; Acosta MC; Evans SE; Breland AB; Eissenberg T
    Addiction; 2005 Apr; 100(4):550-9. PubMed ID: 15784070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit.
    Xian H; Scherrer JF; Madden PA; Lyons MJ; Tsuang M; True WR; Eisen SA
    Nicotine Tob Res; 2003 Apr; 5(2):245-54. PubMed ID: 12745498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing the validity of the Cigarette Dependence Scale and the Fagerström Test for Nicotine Dependence.
    Etter JF
    Drug Alcohol Depend; 2008 May; 95(1-2):152-9. PubMed ID: 18328641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smoking cessation pharmacotherapy.
    Frishman WH
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):287-308. PubMed ID: 19491139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mecamylamine does not precipitate withdrawal in cigarette smokers.
    Eissenberg T; Griffiths RR; Stitzer ML
    Psychopharmacology (Berl); 1996 Oct; 127(4):328-36. PubMed ID: 8923568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced-nicotine content cigarettes: Is there potential to aid smoking cessation?
    Walker N; Bullen C; McRobbie H
    Nicotine Tob Res; 2009 Nov; 11(11):1274-9. PubMed ID: 19793786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes.
    Buchhalter AR; Schrinel L; Eissenberg T
    Nicotine Tob Res; 2001 May; 3(2):111-8. PubMed ID: 11403724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New medications for nicotine dependence treatment.
    Hurt RD
    Nicotine Tob Res; 1999; 1 Suppl 2():S175-9; discussion S207-10. PubMed ID: 11768177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
    Cousins MS; Stamat HM; de Wit H
    Nicotine Tob Res; 2001 May; 3(2):123-9. PubMed ID: 11403726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smoking by patients in a smoke-free hospital: prevalence, predictors, and implications.
    Rigotti NA; Arnsten JH; McKool KM; Wood-Reid KM; Pasternak RC; Singer DE
    Prev Med; 2000 Aug; 31(2 Pt 1):159-66. PubMed ID: 10938217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of cranial electrostimulation therapy on short-term smoking cessation.
    Pickworth WB; Fant RV; Butschky MF; Goffman AL; Henningfield JE
    Biol Psychiatry; 1997 Jul; 42(2):116-21. PubMed ID: 9209728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mecamylamine (a nicotine antagonist) for smoking cessation.
    Lancaster T; Stead LF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001009. PubMed ID: 10796584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of mecamylamine for withdrawal from nicotine dependence.
    Tennant FS; Tarver AL; Rawson RA
    NIDA Res Monogr; 1984 Mar; 49():239-46. PubMed ID: 6434966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clonidine in the treatment of tobacco withdrawal. A comparison with nicotine chewing gum].
    Aparici M; Fernández González AL; Alegría E
    Rev Clin Esp; 1994 Jun; 194(6):453-6. PubMed ID: 8079014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quitting cigarette smoking produces minimal loss of chronic tolerance to nicotine.
    Perkins KA; Gerlach D; Broge M; Sanders M; Grobe J; Fonte C; Cherry C; Wilson A; Jacob R
    Psychopharmacology (Berl); 2001 Oct; 158(1):7-17. PubMed ID: 11685379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.